Ph IIB Ide-Cel Multi-Cohort mono RRMM
Research payments
$7,325,989
Through program year 2020, $7,325,989 in research payments was reported against Ph IIB Ide-Cel Multi-Cohort mono RRMM, across 24 payments, paid by Celgene Corporation.
- Paid by
- Celgene Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $7,325,989 | 24 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Noopur Raje Boston, MA Named on 3 payments
- Ravi Vij Saint Louis, MO Named on 2 payments
- Larry Anderson Dallas, TX Named on 2 payments
- Krina Patel Houston, TX Named on 2 payments
- Nina Shah San Francisco, CA Named on 2 payments
- Madhav Dhodapkar Atlanta, GA Named on 2 payments
- Ran Reshef New York, NY Named on 2 payments
- Peter Bergsagel Scottsdale, AZ Named on 2 payments
- Alexander Stewart Phoenix, AZ Named on 1 payment
- Jesus Berdeja Nashville, TN Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.